RosettaSX: Reliable gene expression signature scoring of cancer models and patients

Julian Kreis1, Boro Nedić2, Johanna Mazur2

  • 1Department of Translational Medicine, Oncology Bioinformatics, Merck KGaA, Darmstadt, Germany; Faculty of Bioscience, University of Heidelberg, Heidelberg, Germany.

Neoplasia (New York, N.Y.)
|September 28, 2021
PubMed